News Releases


2018 | 2017 | 2016 | Archive
Keyword Search
 
DateTitle 
03/20/18ACADIA Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference on March 27, 2018
SAN DIEGO--(BUSINESS WIRE)--Mar. 20, 2018-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the 17th Annual Needham Healthcare Conference on Tuesday, March 27, 2018, at 11:30 a.m. Eastern Time in New York City. A live webcast of ACADIA’... 
Printer Friendly Version
03/06/18ACADIA Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference on March 13, 2018
SAN DIEGO--(BUSINESS WIRE)--Mar. 6, 2018-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the Cowen and Company 38th Annual Health Care Conference on Tuesday, March 13, 2018, at 8:40 a.m. Eastern Time in Boston. A live webcast of ACADI... 
Printer Friendly Version
02/27/18ACADIA Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
-Fourth Quarter and Full Year 2017 Net Sales Grew to $43.6 Million and $124.9 Million, Respectively SAN DIEGO--(BUSINESS WIRE)--Feb. 27, 2018-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced its financial results for the fourth quarter and year ended December... 
Printer Friendly Version
02/20/18ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results on February 27, 2018
ACADIA to Host Conference Call and Webcast on Tuesday, February 27, 2018, at 5:00 p.m. Eastern Time SAN DIEGO--(BUSINESS WIRE)--Feb. 20, 2018-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its financial results for the fourth quarter... 
Printer Friendly Version
01/02/18ACADIA Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference on January 9, 2018
SAN DIEGO--(BUSINESS WIRE)--Jan. 2, 2018-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the 36th Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2018, at 1:30 p.m. Pacific Time in San Francisco. A live webcast of ACAD... 
Printer Friendly Version